Please select the option that best describes you:
Is venetoclax expected to be useful in patients with refractory CLL/SLL who do not have Del(17p)?
Answer from: Medical Oncologist at Academic Institution
Venetoclax is active in all types of CLL including those patients who do not have del(17p). In fact, the data thus far suggests that the durability of response will be better in this group of patients.
Sign in or Register to read more